Background: Catheter ablation is widely accepted intervention for atrial fibrillation (AF) refractory to antiarrhythmic drugs, but limited data are available regarding contemporary trends in major complications and in-hospital mortality due to the procedure. This study was aimed at exploring the temporal trends of in-hospital mortality, major complications, and impact of hospital volume on frequency of AF ablation-related outcomes.
rate of complications. 3, 4 Evolution in catheter techniques 5, 6 and institutional experience have improved safety profile of the procedure.
A plethora of data are available from small series, surveys, randomized controlled trials, and from administrative data sets regarding rate of adverse outcomes associated with AF ablation with most studies reporting complication rates between 2% and 10%. [7] [8] [9] [10] We previously reported on the incidence of in-hospital adverse outcomes associated with AF ablation. 11 Due to varied methods of different studies, realworld complication rate after AF ablation is expected to differ from randomized clinical trials. 12 The aim of our study was to determine in-hospital complication rates associated with AF ablation. We sought to update and compare the findings with our previous report for the years 2000-2010.
METHODS

Data source
The data were obtained from the Nationwide Inpatient Sample (NIS) data set from 2011 to 2014. 13 The NIS is a nationally representative survey of hospitalizations conducted by the Healthcare Cost and Utilization Project in collaboration with the participating states. It is the largest all-payer inpatient data set in the United States. It was designed to approximate 20% stratified sample of United States community hospitals and provides sampling weights to calculate national estimates. 14 NIS includes patients based on discharge data without specifying the nature of admission (observation vs. inpatient). Each entry contains information on demographic details, including age, sex, race, insurance status, primary and secondary procedures, hospitalization outcome, total cost, and length of stay (LOS). The NIS database contains clinical and resource use information, with safeguards to protect the privacy of patients, physicians, and hospitals. The NIS database results have been shown to correlate well with other hospitalization discharge databases in the United States. 15 It has also been used to explain trends in other acute medical and surgical conditions. 16 
Study population
Our target population consisted of hospitalizations during which catheter ablation for AF was performed (2011) (2012) (2013) (2014) . There is no unique procedure code for AF ablation. We searched for hospital admissions with a principal diagnosis of AF (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] code 427.31) during which a catheter ablation procedure (code 37.34) was performed. We excluded patients having a secondary diagnosis of atrial flutter, Wolff-Parkinson-White syndrome, atrioventricular nodal tachycardia, paroxysmal supraventricular tachycardia, paroxysmal ventricular tachycardia, and ventricular premature complexes. Also, to avoid the inclusion of patients undergoing only ablation of the atrioventricular junction, we excluded patients with diagnostic or procedural codes indicating previous or current implantation of a pacemaker or implantable cardioverter defibrillator. Cases with open surgical ablations during the hospitalization also were excluded. Similar methodology has been used previously to identify patients undergoing AF ablation from large administrative databases. 11, 17 The ICD-9-CM codes used to identify each of these diagnoses and procedures are listed in Table S1 .
Outcomes
We investigated the commonly described acute in-hospital complications in the setting of AF ablation procedures. These complications have also been described in other AF ablation studies. 11, 17 Complications available for this analysis included cardiac complications (iatrogenic cardiac complications, pericardial complications, and acute myocardial infarction); pulmonary complications (pneumothorax, postoperative respiratory failure, and iatrogenic complications); neurological complications (stroke and transient ischemic attack corresponding ICD-9-CM diagnosis and procedure codes as used by other investigators to maintain consistency 17, 18 (Table S2) 
Definition of variables
We used NIS variables to identify age, sex, and race. We divided race into whites and non-whites. We divided age into 5 subgroups: 18- Table S3 ). This index contains 17 comorbid conditions with differential weights. The score ranges from 0 to 33, with higher scores corresponding to greater burden of comorbid diseases. Facilities were considered to be teaching hospitals if they had an American Medical Association-approved residency program, were a member of the Council of Teaching Hospitals, or had a full-time equivalent interns and residents to patients' ratio of 0.25 or higher. The bed size cut off points divided into small, medium, and large have been done so that approximately one-third of the hospitals in a given region, location, and teaching status combination would fall within each bed size category. 22 Annual hospital volume was determined on a year-to-year basis using the unique hospital identification number to calculate the total number of procedures performed by a particular institution in a given year. Similarly, comparisons of high-and low-volume centers suggest that high-volume centers have performed > 100 AF ablations. 8 Hence, we divided the annual hospital volume as > 100, between 50 and 100, and < 50.
Statistical analysis
We used weighted numbers for the final analysis. Since this database approximates only 20% stratified sample of US community hospitals, NIS recommends obtaining weighted numbers to calculate regional and national estimate. 23 We used a 2 test to compare categorical variables between patients with and without complications.
We compared continuous variables like LOS by using the Student's t-test. Hierarchical mixed-effects logistic regression models were generated to identify the independent multivariate predictors of 
RESULTS
AF ablation hospitalization, demographics, and comorbidities
We identified 50,969 catheter ablation procedures for AF during the study period (2011) (2012) (2013) (2014) . Baseline characteristics of study population and hospitals where procedures were performed are described in Table 1 . A total of 2,781 complications (5.46%) related to the procedure were reported. Most procedures were performed among patients in the age group 65-79 years, whites, male patients, patients with lower burden of comorbidities as indicated by CCI = 0, hypertensive, Medicaid/Medicare beneficiaries and patients with high household income for ZIP code (76-100th percentile). Also, majority of procedures were performed in large hospitals, hospitals with academic affiliation, hospitals located in southern region, and hospitals with annual procedure volume < 50 (Table 1) . Additionally, comorbidities such as obesity, hypertension, diabetes and congestive heart failure, chronic pulmonary disease, peripheral vascular disease, renal failure, neurological disorder, anemia, and depression were more prevalent among AF ablation patients with complications as shown in Table 1 .
AF ablation-related complication and in-hospital mortality
Overall in-hospital procedure volume decreased from 16, 274 in 2011 to 8,355 in 2014 (relative decrease 48.75%; P-trend < 0.001). We observed a rise in AF-ablation related complication rate, 4.71% in 2011 to 7.42% in 2014 (relative increase 56.37%, P-trend < 0.001).
Insignificant change in in-hospital mortality was observed (0.09% in 2011 to 0.18% in 2014; overall mortality 0.15%, relative increase 60%, P-trend = 0.173). Cardiac complications were most common (2.65%) followed by vascular complications (1.33%), neurological complications (1.05%), and respiratory complications (0.86%; Figure 1 ). Except for overall cardiac complications, a significant rise in all other complications was noticed over the study period. Specifically, postoperative respiratory failure (relative increase 547%, P-trend < 0.001), neurological complications (relative increase 43.85%, P-trend = 0.003), and postoperative infectious complications (relative increase 132.86%, Ptrend < 0.001) showed significant rise during study period. Trend of individual complication between years 2011-2014 is shown in Table 2 .
We also noted higher complication rate associated with lower hospital volume for the AF ablation procedure (Figure 2 ).
On multivariate analysis (Table 3) , we noticed that higher complication rates were significantly associated with female sex (OR = 1.40; 95%CI = 1.17-1.68; P < 0.001), and higher comorbidities indicated by CCI ≥ 2 (OR = 2.84; 95%CI = 2.29-3.52, P < 0.001) when compared to patients with no comorbidities (CCI = 0). Additionally, lower complications were observed when procedure was performed in hospitals with high annual procedure volume (50-100 annual procedures-OR = 0.57, 95%CI = 0.37-0.89, P = 0.014; > 100 annual procedures-OR = 0.50, 95%CI = 0.37-0.99, P = 0.045) as compared to hospitals with < 50 annual procedure volume.
LOS and disposition
Among patients receiving catheter ablation for AF, the cumulative LOS was 2.37 ± 0.03 days, with significantly LOS observed in patients with complications compared to those without any complications (5.06 ± 0.20 vs. 2.22 ± 0.02 days, P < 0.001; Table 1 ). The majority of the patients had a LOS of a day (51.24%) with approximately 28% patients requiring LOS ≥ 3 days (Figure 3) . We also observed an increased disposition to nursing facility in patients with any procedural-related complication (9.34%, P < 0.001) as compared to those without any complications (1.89%, P < 0.001).
DISCUSSION
This study was designed to report contemporary evidence on inpatient AF ablation-related adverse outcomes from year 2011 to 2014 and compare these findings from our previously published study by Deshmukh et al. for years 2000-2010. 11 The main findings of our study are: (1) there was an overall decline in hospitalizations related to AF ablation; (2) overall complication rate related to AF ablation requiring hospitalization was 5.46%, a rising trend of complications was noticed during study period; (3) cumulative AF ablation-related in-hospital mortality rate during study period was 1.5 per 1,000 procedures; (4) cardiac, vascular, and neurological complications were most common complications related to AF ablation-related hospitalizations; (5) female sex and low annual hospital volume of procedure were significantly associated with worse adverse outcomes following AF ablation procedure requiring hospitalization.
With advancements in catheter techniques and expertise, AF ablation has been gaining popularity as an outpatient procedure. 24 Inpatient population included in current study is expected to be sicker compared to our previously published study for years 2000-2010 11 as AF ablation was primarily performed in inpatient settings during last decade. We noted significant differences while comparing this study to our previously published study for years 2000-2010. 11 We noted a lower utilization of AF ablation among very elderly patients (≥80 years of age). Overall complication rates were lower (5.44% vs. 6.29%) for current study period (2011) (2012) (2013) (2014) . Current study also noted lower mortality after AF ablation (0.15% vs. 0.42%). Cardiac complications remain the most common but slight increase in frequency of cardiac complications was noted for current study period (2.65% vs.
2.54%). But similar to our study for years 2000-2010, 11 higher annual Our study reported decline in the frequency of in-hospital AF ablation procedure in recent years (2011) (2012) (2013) (2014) . These findings contradict the findings of large studies done in last decade. 11, 18, 25 Largely, these findings reflect the shifting trends toward the outpatient performance of the procedure. With evolving technology and institutional experience, safety and efficacy of the procedure has risen tremendously in recent years, as noted by previously published studies. 24, 26 Furthermore, due to improved efficacy, need of repeated procedure to achieve the success has declined, which partly explains the declining frequency of the in-hospital AF ablation procedure. Our estimated numbers cannot account for procedures that are performed as outpatient for observation.
TA B L E 3 Multivariate analysis of mortality and complications
MV of mortality and complications
Variables
Our findings of complication rate of 5.46% was derived from a larger sample and hence more reflective of current practices compared to those studies performed at single centers 10, 27 with great expertise and large annual hospital volume of AF ablation procedure. Our study was designed to minimize bias related to sample size of study and annual hospital volume of AF ablation procedures. Similar studies have been performed in the past using large national patient database 11, 17, 18 but combined complication rate in our study is lower than these studies, reflecting the effect of institutional experience. Our study also showed an increasing trend of complications related to AF ablation during study period as opposed to previously observed trends. 28 This is a reflection of the fact that our study included a sicker pool of patients requiring hospitalization for AF ablation, as well as an increasing number of centers with variable experience and case volume are now performing the procedure. The overall magnitude of such centers has increased drastically in recent years. 18 Our study showed cumulative AF ablation-related in-hospital mortality rate of 0.15% during the study period. Previously published large size studies from national databases reported slightly higher in-hospital mortality rates. 11, 18, 29 This is an interesting finding and reflects salutary effect of refinement in procedure, technology, and institutional volume leading to declining in-hospital mortality due to AF ablation in recent times.
Complication rates were found to be significantly higher in females compared to males. These findings were consistent with previously published studies 30, 31 and appear to be multifactorial in origin. When compared to male patients, female patients undergoing catheter ablation for AF tend to be older, have higher comorbidities (hypertension, valvular heart disease), higher CHADS2/CHA 2 DS 2 -VASc scores, and usually have longer history of AF.
Annual hospital volume of AF ablation procedure was found to be an important predictor of complications in our study. Similar results were shown in previously published studies. 11, 28 These findings were consistent with the general observation that increased institutional experience is associated with better outcomes for various procedures. 32, 33 In terms of specific complications, cardiac adverse events were found to be most common in our studies and demonstrated only slight rise over the study period, which did not reach statistical significance (relative increase 9.11%, P-trend = 0.323). Similar results were obtained in previous studies. 7, 11 Iatrogenic cardiac complication including cardiac tamponade was 0.85%, which is lower as compared to previous studies, 27, 28 partially as a result of increased utilization of intracardiac echocardiography and improved catheter techniques in recent years.
Vascular complications reported in our study were consistent with previous studies 11, 17, 18 but we noticed increased trend of these complications over study period. Early institutional experience and increased utilization of AF ablation in elderly patients contribute to these findings. Similarly, neurological complications (stroke/TIA) in our study were consistent with previously published literature. 11, 34 
LIMITATIONS
Our study has several limitations. First, the NIS is a deidentified administrative database, making it impossible to validate individual ICD-9-CM codes. This significantly affects the sensitivity and specificity when applying the diagnostic codes. Studies based on data mining are susceptible to errors related to coding. Further, we could not eliminate the effect of unmeasured confounders that might have contributed to the reporting of adverse effects. The administrative data used in this analysis lack the detail that is available in trials and registries. Physician characteristics and full assessment of comorbidities (i.e., including outpatient diagnoses) were unavailable for the analyses. Last, NIS includes patients based on discharge data; hence, outpatient AF ablation procedures were not included in our study who relatively are less sick and expected to have lower complications and mortality. Despite these limitations, our study has several advantages.
We employed a large sample size. Patients selected in our study are representative of general population of AF ablation patients in the United States requiring hospitalization than those included in prior studies performed at single centers with high level of expertise and institutional experience. Our study also provides recent trends in utilization and complication related to AF ablation, which can be used to plan appropriate application of procedure in health care across the country.
In conclusion, our study demonstrates that frequency of hospitalizations related to AF ablation is decreasing, suggesting the majority of the procedures are being performed in the outpatient setting.
Overall complication rates were lower during our study period as compared to studies done in past 2 decades. Female sex and annual hospital volume of procedure were most important predictors of complication.
